Idiopathic pulmonary fibrosis: is it a familial disease?

被引:18
|
作者
Allam, J. Shirine
Limper, Andrew H.
机构
[1] Mayo Clin, Coll Med, Dept Internal Med, Div Pulm & Crit Care, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Thorac Dis Res Unit, Rochester, MN 55905 USA
关键词
familial interstitial pulmonary fibrosis; genetics; interstitial pulmonary fibrosis; surfactant proteins;
D O I
10.1097/01.mcp.0000239546.24831.61
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of review Idiopathic pulmonary fibrosis is a progressively fatal interstitial lung disease associated with pathological findings of usual interstitial, pneumonia. Its pathognesis is unknown, and there are no proven effective therapies Familial cases account for 0.5-2% of idiopathic pulmonary fibrosis. Familial idiopathic pulmonary fibrosis occurs as an autosomal dominant disorder with variable penetrance. The clinical characteristics of familial idiopathic pulmonary fibrosis are indistinguishable from sporadic idiopathic pulmonary fibrosis. These marked similarities support the hypothesis there may, in part, be a genetic basis for idiopathic pulmonary fibrosis. Recent findings Many investigations have evaluated genetic polymorphisms and idiopathic pulmonar fibrosis. Candidate genes include and surfactant protein genes. To date, no gene has been consistently identified to be-associated with idiopathic pulmonary fibrosis. Recent studies in familial, idiopathic pulmonary fibrosis have demonstrated a strong association with surfactant protein C gene mutations in one large kindred. Summary The pathogenesis of both idiopathic pulmonary fibrbsis and familial idiopathic pulmonary fibrosis remains unclear. A consistent genetic basis has not yet been demonstrated in all cases. Other factors, including variable gene expression, co-carriage of other modifying genes and environmental stimuli, particularly cigarette smoke, significantly contribute to disease expression.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 50 条
  • [41] Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
    Tomos, Ioannis
    Roussis, Ioannis
    Matthaiou, Andreas M.
    Dimakou, Katerina
    BIOMEDICINES, 2023, 11 (10)
  • [42] Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk
    Mohammadi-Nejad, Ali-Reza
    Allen, Richard J.
    Kraven, Luke M.
    Leavy, Olivia C.
    Jenkins, R. Gisli
    V. Wain, Louise
    Auer, Dorothee P.
    Sotiropoulos, Stamatios N.
    DEMISTIFI Consortium
    EBIOMEDICINE, 2022, 86
  • [43] Evolving Genomic Approaches to Idiopathic Pulmonary Fibrosis: Moving Beyond Genes
    Kass, Daniel J.
    Kaminski, Naftali
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2011, 4 (05): : 372 - 379
  • [44] Pathway-based detection of idiopathic pulmonary fibrosis at an early stage
    Zhou, Guojun
    Zhang, Fangxia
    Liu, Yufang
    Sun, Bin
    MOLECULAR MEDICINE REPORTS, 2017, 15 (04) : 2023 - 2028
  • [45] Idiopathic pulmonary fibrosis (IPF) in upper Egypt, a single center study
    Rashad, M. Alaa
    Ibrahim, Ahmed K.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2015, 64 (04): : 915 - 919
  • [46] Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis
    Pallante, Pierlorenzo
    Malapelle, Umberto
    Nacchio, Mariantonia
    Sgariglia, Roberta
    Galati, Domenico
    Capitelli, Ludovica
    Zanotta, Serena
    Galgani, Mario
    Piemonte, Erica
    Zamparelli, Alessandro Sanduzzi
    Rea, Gaetano
    Bocchino, Marialuisa
    DIAGNOSTICS, 2021, 11 (07)
  • [47] Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
    Spagnolo, Paolo
    Cottin, Vincent
    JOURNAL OF MEDICAL GENETICS, 2017, 54 (02) : 73 - 83
  • [48] A HAPLOTYPE OF CYCLOOXYGENASE-2 GENE IS ASSOCIATED WITH IDIOPATHIC PULMONARY FIBROSIS
    Xaubet, A.
    Fu, W. J.
    Li, M.
    Serrano-Mollar, A.
    Ancochea, J.
    Molina-Molina, M.
    Rodriguez-Becerra, E.
    Morell, F.
    Rodriguez-Arias, J. M.
    Pereda, J.
    Casanova, A.
    Molins, L.
    Picado, C.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2010, 27 (02) : 121 - 130
  • [49] Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis
    Greene, KE
    King, TE
    Kuroki, Y
    Bucher-Bartelson, B
    Hunninghake, GW
    Newman, LS
    Nagae, H
    Mason, RJ
    EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (03) : 439 - 446
  • [50] Circulating inflammatory cytokines and risk of idiopathic pulmonary fibrosis: a Mendelian randomization study
    Qinyao Jia
    Yanmei Lei
    Shaoping Chen
    Shengming Liu
    Tao Wang
    Yao Cheng
    BMC Pulmonary Medicine, 23